Literature DB >> 6306483

Bicuculline insensitive effects of baclofen.

L K Rägo, A M Zarkovsky.   

Abstract

The action of bicuculline on the effect of baclofen and muscimol were investigated in behavioural, biochemical and binding studies in rats. Both (+/-)-baclofen (5 mg kg-1 i.p.) and muscimol (1.4 mg kg-1 i.p.) decreased motor activity and aggressiveness. In investigated doses the drugs mentioned raised DOPAC concentration in the rat striatum. (+)-Bicuculline (1.25 mg kg-1 s.c.) potentiated the behavioural effects of baclofen but failed to alter significantly those of muscimol. The DOPAC rise caused by baclofen and muscimol was not substantially affected by bicuculline. 3H-GABA binding to bicuculline insensitive GABA sites was determined in the rat striatal tissue. (+)-Bicuculline was used to suppress bicuculline sensitive GABA binding. Two GABA binding sites were revealed in the presence of calcium ions of which the low affinity site (KD = 447 nM, B max = 109 pmol g-1 protein) was affected by bicuculline whereas the high affinity site (KD = 8 nM, B max = 24 pmol g-1 protein) was not. Muscimol, GABA and (+/-)-baclofen bound in vitro to these GABA sites with IC50, 44, 49 and 431 nM respectively. The involvement of bicuculline insensitive GABA sites in the effects of (+/-)-baclofen on behaviour and dopamine metabolism is suggested.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306483     DOI: 10.1007/bf00512391

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.

Authors:  I Kääriäinen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-09

2.  The interaction of baclofen (beta-(4-chlorophenyl)Gaba) with GABA systems in rat brain: evidence for a releasing action.

Authors:  P J Roberts; H K Gupta; N S Shargill
Journal:  Brain Res       Date:  1978-10-20       Impact factor: 3.252

3.  Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.

Authors:  P C Waldmeier; L Maitre
Journal:  Eur J Pharmacol       Date:  1978-01-15       Impact factor: 4.432

4.  The action of beta-phenyl-GABA derivatives on neurones of the cat cerebral cortex.

Authors:  J Davies; J C Watkins
Journal:  Brain Res       Date:  1974-04-26       Impact factor: 3.252

5.  Drug effects in a GABA-dependent rotational behaviour model and on [3H]-GABA receptor binding: studies with the enantiomers of baclofen HCl [proceedings].

Authors:  A J Cross; J L Waddington; T J Crow
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

6.  GABA and baclofen potentiate the K+-evoked release of methionine-enkephalin from rat striatal slices.

Authors:  J Sawynok; F S Labella
Journal:  Eur J Pharmacol       Date:  1981-03-12       Impact factor: 4.432

7.  In vivo release of endogenous gamma-aminobutyric acid from rat striatum: effects of muscimol, oxotremorine, and morphine.

Authors:  J A van der Heyden; K Venema; J Korf
Journal:  J Neurochem       Date:  1980-06       Impact factor: 5.372

8.  3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain.

Authors:  D R Hill; N G Bowery
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

9.  Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.

Authors:  G Gianutsos; K E Moore
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

10.  Differential effects of IV and IP muscimol on central dopamine metabolism.

Authors:  A L Gundlach; P M Beart
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.